These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 18559656)

  • 21. Tamoxifen usage correlates with increased risk of Parkinson's disease in older women with breast cancer: a case-control study in Taiwan.
    Lin HF; Liao KF; Chang CM; Lin CL; Lai SW
    Eur J Clin Pharmacol; 2018 Jan; 74(1):99-107. PubMed ID: 28967041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The long-acting dopamine receptor agonist cabergoline in early Parkinson's disease: final results of a 5-year, double-blind, levodopa-controlled study.
    Bracco F; Battaglia A; Chouza C; Dupont E; Gershanik O; Marti Masso JF; Montastruc JL;
    CNS Drugs; 2004; 18(11):733-46. PubMed ID: 15330687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of developing Parkinson's disease among patients with asthma: a nationwide longitudinal study.
    Cheng CM; Wu YH; Tsai SJ; Bai YM; Hsu JW; Huang KL; Su TP; Li CT; Tsai CF; Yang AC; Lin WC; Pan TL; Chang WH; Chen TJ; Chen MH
    Allergy; 2015 Dec; 70(12):1605-12. PubMed ID: 26310430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective cohort study of type 2 diabetes and the risk of Parkinson's disease.
    Driver JA; Smith A; Buring JE; Gaziano JM; Kurth T; Logroscino G
    Diabetes Care; 2008 Oct; 31(10):2003-5. PubMed ID: 18599528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Living near major roads and the incidence of dementia, Parkinson's disease, and multiple sclerosis: a population-based cohort study.
    Chen H; Kwong JC; Copes R; Tu K; Villeneuve PJ; van Donkelaar A; Hystad P; Martin RV; Murray BJ; Jessiman B; Wilton AS; Kopp A; Burnett RT
    Lancet; 2017 Feb; 389(10070):718-726. PubMed ID: 28063597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Premotor symptoms and the risk of Parkinson's disease: A case-control study in Mexican population.
    Rodríguez-Violante M; de Saráchaga AJ; Cervantes-Arriaga A; Davila-Avila NM; Carreón-Bautista E; Estrada-Bellmann I; Parra-López G; Cruz-Fino D; Pascasio-Astudillo F
    Clin Neurol Neurosurg; 2017 Sep; 160():46-49. PubMed ID: 28644969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antecedent clinical features associated with dementia in Parkinson's disease.
    Stern Y; Marder K; Tang MX; Mayeux R
    Neurology; 1993 Sep; 43(9):1690-2. PubMed ID: 8414013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parkinson's disease and colorectal cancer risk-A nested case control study.
    Boursi B; Mamtani R; Haynes K; Yang YX
    Cancer Epidemiol; 2016 Aug; 43():9-14. PubMed ID: 27232063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of Parkinson's disease following zolpidem use: a retrospective, population-based cohort study.
    Huang HC; Tsai CH; Muo CH; Lin KH; Lu MK; Sung FC; Kao CH
    J Clin Psychiatry; 2015 Jan; 76(1):e104-10. PubMed ID: 25650675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical problems in non-fluctuating patients with Parkinson's disease: a community-based study.
    Larsen JP; Karlsen K; Tandberg E
    Mov Disord; 2000 Sep; 15(5):826-9. PubMed ID: 11009186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Parkinson disease with old-age onset: a comparative study with subjects with middle-age onset.
    Diederich NJ; Moore CG; Leurgans SE; Chmura TA; Goetz CG
    Arch Neurol; 2003 Apr; 60(4):529-33. PubMed ID: 12707066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of calcium channel blockers and Parkinson's disease.
    Pasternak B; Svanström H; Nielsen NM; Fugger L; Melbye M; Hviid A
    Am J Epidemiol; 2012 Apr; 175(7):627-35. PubMed ID: 22387374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased risk of Parkinson's disease in patients with end-stage renal disease: a retrospective cohort study.
    Wang IK; Lin CL; Wu YY; Chou CY; Lin SY; Liu JH; Yen TH; Huang CC; Sung FC
    Neuroepidemiology; 2014; 42(4):204-10. PubMed ID: 24751820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sleep disorders and an increased risk of Parkinson's disease in individuals with non-apnea sleep disorders: a population-based cohort study.
    Hsiao YH; Chen YT; Tseng CM; Wu LA; Perng DW; Chen YM; Chen TJ; Chang SC; Chou KT
    J Sleep Res; 2017 Oct; 26(5):623-628. PubMed ID: 28470725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Real-world pharmacological treatment patterns of patients with young-onset Parkinson's disease in Japan: a medical claims database analysis.
    Kasamo S; Takeuchi M; Ikuno M; Kawasaki Y; Tanaka S; Takahashi R; Kawakami K
    J Neurol; 2019 Aug; 266(8):1944-1952. PubMed ID: 31076875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of Restless Legs Syndrome With Incident Parkinson's Disease.
    Szatmari S; Bereczki D; Fornadi K; Kalantar-Zadeh K; Kovesdy CP; Molnar MZ
    Sleep; 2017 Feb; 40(2):. PubMed ID: 28364505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does Late Levodopa Administration Delay the Development of Dyskinesia in Patients with De Novo Parkinson's Disease?
    Chung SJ; Yoo HS; Lee HS; Jeong HE; Kim SJ; Oh JS; Kim JS; Sohn YH; Lee PH
    CNS Drugs; 2018 Oct; 32(10):971-979. PubMed ID: 30027399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Co-morbidity and polypharmacy in Parkinson's disease: insights from a large Scottish primary care database.
    McLean G; Hindle JV; Guthrie B; Mercer SW
    BMC Neurol; 2017 Jul; 17(1):126. PubMed ID: 28666413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Environmental risk factors for Parkinson's disease and parkinsonism: the Geoparkinson study.
    Dick FD; De Palma G; Ahmadi A; Scott NW; Prescott GJ; Bennett J; Semple S; Dick S; Counsell C; Mozzoni P; Haites N; Wettinger SB; Mutti A; Otelea M; Seaton A; Söderkvist P; Felice A;
    Occup Environ Med; 2007 Oct; 64(10):666-72. PubMed ID: 17332139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A 12-year population-based study of freezing of gait in Parkinson's disease.
    Forsaa EB; Larsen JP; Wentzel-Larsen T; Alves G
    Parkinsonism Relat Disord; 2015 Mar; 21(3):254-8. PubMed ID: 25603767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.